Literature DB >> 16100013

Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis.

Carlo Agostini1, Anna Cabrelle, Fiorella Calabrese, Michela Bortoli, Elisa Scquizzato, Samuela Carraro, Marta Miorin, Bianca Beghè, Livio Trentin, Renato Zambello, Monica Facco, Gianpietro Semenzato.   

Abstract

RATIONALE: Receptor expression dictates the spectrum of chemokine actions on immunocompetent cells. We have previously shown that the chemokine receptor CXCR3 is highly expressed by T-helper type 1 (Th1) cells infiltrating the lungs of patients with sarcoidosis.
OBJECTIVES: The evaluation of the role of Bonzo/CXCR6 and its ligand CXCL16 in the pathogenesis of sarcoidosis.
METHODS: Immunocompetent cells infiltrating sarcoid lung have been evaluated by flow cytometry, confocal microscopy, immunohistochemical and molecular analysis, and functional assays. MAIN
RESULTS: Th1 cells isolated from the bronchoalveolar lavage of patients with sarcoidosis and T-cell alveolitis coexpressed CXCR3 and CXCR6. Immunohistochemical analysis of lung specimens has shown that CXCR6+ T cells infiltrated lung interstitium surrounding the central core of the granuloma. The CXCR6 ligand CXCL16 was abundantly expressed by macrophages infiltrating sarcoid tissue and/or forming the granuloma core. From a functional point of view, sarcoid Th1 cells were able to respond to CXCL10 and CXCL16 in migratory assay. In vitro kinetic studies demonstrated that, although CXCR3 was rapidly induced by interleukin (IL)-15 and IL-18, CXCR6 induction was slow (8 d) and mainly regulated by IL-15.
CONCLUSIONS: T cells coexpressing CXCR3 and CXCR6 act coordinately with respective ligands and Th1 inflammatory cytokines in the alveolitic/granuloma phases of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100013     DOI: 10.1164/rccm.200501-142OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

1.  CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers.

Authors:  Angela J Morgan; Cristina Guillen; Fiona A Symon; Surinder S Birring; James J Campbell; Andrew J Wardlaw
Journal:  Immunobiology       Date:  2008-03-07       Impact factor: 3.144

2.  Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections.

Authors:  M M Gaida; F Günther; C Wagner; H Friess; N A Giese; J Schmidt; G M Hänsch; M N Wente
Journal:  Clin Exp Immunol       Date:  2008-09-05       Impact factor: 4.330

3.  CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen-induced Th2 lung inflammation but is only a weak mediator of chemotaxis.

Authors:  Markus Latta; Karkada Mohan; Thomas B Issekutz
Journal:  Immunology       Date:  2007-04-16       Impact factor: 7.397

4.  Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis.

Authors:  Elliott D Crouser; Daniel A Culver; Kenneth S Knox; Mark W Julian; Guohong Shao; Susamma Abraham; Sandya Liyanarachchi; Jennifer E Macre; Mark D Wewers; Mikhail A Gavrilin; Patrick Ross; Abbas Abbas; Charis Eng
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

5.  No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.

Authors:  Maria Wikén; Farah Idali; Muntasir Abo Al Hayja; Johan Grunewald; Anders Eklund; Jan Wahlström
Journal:  Respir Res       Date:  2010-09-02

6.  CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.

Authors:  Y Nishioka; K Manabe; J Kishi; W Wang; M Inayama; M Azuma; S Sone
Journal:  Clin Exp Immunol       Date:  2007-06-05       Impact factor: 4.330

7.  CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity.

Authors:  Christine M Freeman; Jeffrey L Curtis; Stephen W Chensue
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

Review 8.  Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.

Authors:  Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

9.  The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.

Authors:  Merav Darash-Yahana; John W Gillespie; Stephen M Hewitt; Yun-Yun K Chen; Shin Maeda; Ilan Stein; Satya P Singh; Roble B Bedolla; Amnon Peled; Dean A Troyer; Eli Pikarsky; Michael Karin; Joshua M Farber
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

10.  CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.

Authors:  Jianhua Wang; Yi Lu; Jingchen Wang; Alisa E Koch; Jian Zhang; Russell S Taichman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.